Femasys Inc. Common Stock
Veridion Score
Composite trend over time
Why is FEMY moving today?
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for FEMY.
FEMY insider activity
Femasys Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for FEMY.
FEMY contract awards, year to date.
Public federal awards linked to this ticker.
FEMY lobbying filings, year to date.
Registered lobbying filings matched to Femasys Inc. Common Stock.